Macrogenics Inc (MGNX)
4.37
-0.75
(-14.65%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.05
(+1.14%)
After-Hours: 20:00
Macrogenics Cash from Investing (Quarterly): 24.79M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 24.79M |
| December 31, 2023 | 38.82M |
| September 30, 2023 | -33.52M |
| June 30, 2023 | -113.48M |
| March 31, 2023 | 28.10M |
| December 31, 2022 | -5.788M |
| September 30, 2022 | 71.95M |
| June 30, 2022 | 23.04M |
| March 31, 2022 | -18.48M |
| December 31, 2021 | -13.55M |
| September 30, 2021 | -2.617M |
| June 30, 2021 | 13.82M |
| March 31, 2021 | -34.26M |
| December 31, 2020 | -16.08M |
| September 30, 2020 | -43.28M |
| June 30, 2020 | 41.01M |
| March 31, 2020 | 10.56M |
| December 31, 2019 | 7.626M |
| September 30, 2019 | -6.372M |
| June 30, 2019 | -10.12M |
| March 31, 2019 | -70.49M |
| December 31, 2018 | 45.07M |
| September 30, 2018 | -0.006M |
| Date | Value |
|---|---|
| June 30, 2018 | -7.811M |
| March 31, 2018 | 19.39M |
| December 31, 2017 | 8.639M |
| September 30, 2017 | 4.464M |
| June 30, 2017 | 73.13M |
| March 31, 2017 | -8.357M |
| December 31, 2016 | 2.034M |
| September 30, 2016 | -3.163M |
| June 30, 2016 | -56.59M |
| March 31, 2016 | -12.53M |
| December 31, 2015 | -145.69M |
| September 30, 2015 | -2.608M |
| June 30, 2015 | -2.812M |
| March 31, 2015 | -0.997M |
| December 31, 2014 | -1.658M |
| September 30, 2014 | -0.672M |
| June 30, 2014 | -0.795M |
| March 31, 2014 | -0.447M |
| December 31, 2013 | -0.924M |
| September 30, 2013 | -1.161M |
| June 30, 2013 | -0.4509M |
| March 31, 2013 | -0.4251M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-113.48M
Minimum
Jun 2023
71.95M
Maximum
Sep 2022
-1.892M
Average
-4.202M
Median
Cash from Investing (Quarterly) Benchmarks
| Moderna Inc | 118.00M |
| Allurion Technologies Inc | -0.104M |
| Novavax Inc | -7.25M |
| United Therapeutics Corp | 735.30M |
| MEI Pharma Inc | 0.122M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -45.64M |
| Cash from Financing (Quarterly) | 0.248M |
| Free Cash Flow | -113.88M |
| Free Cash Flow Per Share (Quarterly) | -0.7562 |
| Free Cash Flow to Equity (Quarterly) | -47.10M |
| Free Cash Flow Yield | -41.94% |